Quantitative Measurement of IgG to Severe Acute Respiratory Syndrome Coronavirus-2 Proteins Using ImmunoCAP

BACKGROUND: Detailed understanding of the immune response to severe acute respiratory syndrome coronavirus (SARS-CoV)-2, the cause of coronavirus disease 2019 (CO­VID-19) has been hampered by a lack of quantitative antibody assays. OBJECTIVE: The objective was to develop a quantitative assay for IgG...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int Arch Allergy Immunol
Autors principals: Keshavarz, Behnam, Wiencek, Joesph R., Workman, Lisa J., Straesser, Matthew D., Muehling, Lyndsey M., Canderan, Glenda, Drago, Fabrizio, Bonham, Catherine A., Sturek, Jeffrey M., Ramani, Chintan, McNamara, Coleen A., Woodfolk, Judith A., Kadl, Alexandra, Platts-Mills, Thomas A.E., Wilson, Jeffrey M.
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2021
Matèries:
Experimental Immunology − Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018212/
https://ncbi.nlm.nih.gov/pubmed/33621972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000514203
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars